Jinghua Pharma: Use Capital Markets To Modernize Chinese Medicine
This article was originally published in PharmAsia News
Executive Summary
Jinghua Pharma listed its initial public offering on the Shenzhen Stock Exchange Feb. 3, and it hopes to use the capital to further develop Chinese Medicine in China